VIRBAC chart

Last update: 2022-12-30
Key statistics and financials
Revenue per share 136.14
Dividend & Yield1.25€ (0.45%)
Beta 0.88
Market capitalization 2.43B
Operating cash flow 83.93M
ESG Scores unknown

Company description

Virbac SA manufactures and sells a range of products and services for companion and food-producing animals in France, Europe, Latin America, North America, the Asia Pacific, the Middle East, and Africa. The company offers a range of vaccines, dental hygiene, reproduction, dermatology, parasiticides, diagnostic, antibiotics, and aquaculture products; and veterinary medicines for anesthesia, geriatrics, behavior, and injectable micronutrients, as well as petfood and electronic identification. It serves veterinarians, farmers, and pet owners. Virbac SA was founded in 1968 and is headquartered in Carros, France.

Sector: Healthcare - Industry: Drug Manufacturers—General

Financial Ratios
Quick Ratio0.96
Working Capital0.45
Return On Equity0.16
Debt To Equity0.02
Fixed Asset Ratio0.18
Fixed Interest Cover28.56

Financial data

Financial Statements

Cashflow Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Change To Liabilities -11.16M 2.71M 12.08M 18.69M
Total Cashflows From Investing Activities -27.16M -16.13M 339.52M -51.21M
Net Borrowings -23.27M -61.97M -337.63M -21.84M
Total Cash From Financing Activities -44.45M -79.48M -349.89M -91.69M
Change To Operating Activities 11.08M 13.46M -336k 10.99M
Issuance Of Stock 314k 1.93M 143k 174k
Net Income 20.1M 51.55M 136.04M 113.16M
Change In Cash 11.94M 36.26M 99.72M -7.43M
Effect Of Exchange Rate -68k 261k -8.83M 5.57M
Total Cash From Operating Activities 83.62M 131.61M 118.92M 129.9M
Depreciation 42.73M 54.73M 47.63M 43.34M
Change To Account Receivables 9.63M 2.46M -7.63M -5.62M
Other Cashflows From Financing Activities -21.5M -19.44M -12.4M -63.68M
Change To Netincome 23.88M 15.78M -16.59M 56.48M
Capital Expenditures -25.82M -16.72M -22.46M -33.65M

Income Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Research Development
Income Before Tax 41.35M 77.86M 173.63M 159.3M
Net Income 20.1M 51.55M 136.04M 113.16M
Selling General Administrative 446.32M 453.86M 439.15M 494.6M
Gross Profit 574.64M 623.54M 617.56M 712.85M
Ebit 75.03M 104.82M 121.78M 170.84M
Operating Income 75.03M 104.82M 121.78M 170.84M
Interest Expense -17.79M -17.8M -10.72M -5.98M
Income Tax Expense 20.37M 23.44M 33.29M 43.61M
Total Revenue 868.93M 938.34M 934.2M 1.06B
Cost Of Revenue 294.29M 314.81M 316.64M 351.11M
Total Other Income ExpenseNet -33.68M -26.96M 51.85M -11.53M
Net Income From Continuing Ops 20.98M 54.42M 140.34M 115.69M
Net Income Applicable To Common Shares 20.1M 51.55M 136.04M 113.16M

Balance Sheet Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Total Liabilities 776.93M 771.38M 454.28M 476.36M
Total Stockholder Equity 460.31M 517.78M 620.97M 724.93M
Other Current Liabilities 77.06M 94.17M 112.03M 117.3M
Total Assets 1.27B 1.32B 1.11B 1.2B
Common Stock 10.57M 10.57M 10.57M 10.57M
Other Current Assets 2.09M 3.25M 1.65M 3.95M
Retained Earnings 21.19M 52.64M 137.13M 114.25M
Treasury Stock 422.01M 448.04M 466.73M 593.58M
Cash 62.81M 93.66M 181.89M 172.79M
Total Current Liabilities 331.26M 372.49M 311.69M 370.75M
Other Stockholder Equity 422.01M 448.04M 466.73M 593.58M
Property, Plant, and Equipment 236.69M 258.8M 239.01M 256.13M
Total Current Assets 407.55M 450.87M 569.77M 624.67M
Net Tangible Assets -144.42M -67.23M 340.93M 435.66M
Net Receivables 140.87M 140.82M 162.13M 169M
Accounts Payable 86.8M 90.07M 96.54M 127.6M


Insider Transactions

Here are the insider transactions of stock shares related to VIRBAC:

Filer Name Transaction Text Ownership Date Filer Relation Shares
NO DATA

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to VIRBAC. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on VIRBAC

Here is the result of two systematic investment strategies applied to VIRBAC. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on VIRBAC

The following chart shows the equity curve of the two systematic investment strategies applied to VIRBAC:

VIRBAC automated entries

The systematic investment strategy that buys the first day of the month would give a performance of 112.7% on the backtest period.

Performance at glance

Performance

112.7 %

Latent gain

1983.8 €

Invested capital

1760.2 €

Annualized return

27.62 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on VIRBAC

This is the result of two momentum investment strategies applied to VIRBAC. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on VIRBAC

The following chart shows all the entries opened by the momentum investment system on VIRBAC:

VIRBAC momentum entries
  • The first momentum investment strategy would give 144.15% of return on VIRBAC. That represents 7614.1€ of latent gain with 5281.9€ of employed capital.
  • The second momentum investment strategy would give 148.73% of return on VIRBAC. That represents 3731.3€ of latent gain with 2508.7€ of employed capital.
Performance at glance (1Q Momentum)

Performance

144.15 %

Latent gain

7614.1 €

Invested capital

5281.9 €

Annualized return

51.03 %
Performance at glance (2Q Momentum)

Performance

148.73 %

Latent gain

3731.3 €

Invested capital

2508.7 €

Annualized return

41.31 %

Momentum equity curve on VIRBAC

The following chart shows the equity curve of the two momentum strategies applied to VIRBAC:

VIRBAC momentum equity

Note: the dividends potentially given by VIRBAC are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on VIRBAC

The following chart shows the employed capital evolution of the two momentum strategies on VIRBAC since the beginning:

VIRBAC

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250€, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000€.


Buy the dip strategy result on VIRBAC

Buy the dip entry openings on VIRBAC

VIRBAC

The performance achieved by the robo-advisor on VIRBAC is 106.14%. That represents 642.6$ of latent gain with 605.4€ of employed capital. The following chart shows VIRBAC stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of VIRBAC, and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

106.14 %

Latent gain

642.6 €

Invested capital

605.4 €

Annualized return

51.03 %

Equity curve of the strategy applied to VIRBAC

The following chart shows the result of the investment strategy applied to VIRBAC:

VIRBAC

Note: the dividends potentially given by VIRBAC are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on VIRBAC

The following chart shows the employed capital evolution since the beginning of the investment strategy on VIRBAC:

VIRBAC

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on VIRBAC

In this section, I will compare the three previous investment strategies applied to VIRBAC.

Equity curve comparison on VIRBAC

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

VIRBAC investment strategy comparison

Employed capital comparison on VIRBAC

VIRBAC investment comparison

Performance comparison on VIRBAC

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment 112.7% 1983.8€ 1760.2€ 27.62%
Momentum 1 quarter 144.15% 7614.1€ 5281.9€ 37.54%
Momentum 2 quarters 148.73% 3731.3€ 2508.7€ 41.31%
Non-directional 106.14% 642.6€ 605.4€ 51.03%
Annualized return comparison

Automatic investment

27.62 %

Momentum 1Q

41.31 %

Momentum 2Q

41.31 %

Non-directional

51.03 %

Correlated stocks

Here are the most positively and negatively correlated stocks with VIRBAC:

Positive correlations

Most correlated stocks this year

  • VIRBAC

  • Most correlated stocks last 3 months

  • VIRBAC
  • FINANCIERE ODET

  • Negative correlation

    Most negatively correlated stocks this year


    Most negatively correlated stocks last 3 months

  • CHINA ENV TEC

  • Note: The algorithm computes the probability of correlation between VIRBAC and the other stocks. There may be false positives or some missing correlated stocks. If the price of VIRBAC does not vary for 36 weeks, the correlation calculation result will be wrong.


    Company information

    Company name VIRBAC
    Country France
    City Carros
    Address 13e rue LID - BP 27
    Phone 33 4 92 08 71 00
    Website corporate.virbac.com
    FullTime employees 5120
    Industry Drug Manufacturers—General
    Sector Healthcare
    Exchange XPAR
    Ticker VIRP.XPAR
    Market www.euronext.com

    VIRBAC ESG Scores

    Environment scores

    Environment ESG Factors Scores
    Environment Score 0
    Peer Environment Performance unknown
    Environment Percentile unknown
    Palm Oil unknown
    Nuclear unknown
    Fur Leather unknown
    GMO unknown
    Coal unknown
    Pesticides unknown
    Animal Testing unknown

    Social scores

    Social ESG Factors Scores
    Social Score 0
    Peer Social Performance unknown
    Social Percentile unknown
    Highest Controversy unknown
    Peer Highest Controversy Performance unknown
    Adult unknown
    Gambling unknown
    Alcoholic unknown
    Tobacco unknown
    Catholic unknown
    Controversial Weapons unknown
    Small Arms unknown
    Military Contract unknown
    Peer Count unknown

    Related Controversy:


    Governance scores

    Governance ESG Factors Scores
    Governance Score 0
    Peer Governance Performance unknown
    Governance Percentile unknown

    ESG at glance
    Total ESG Scores: unknown
    Environment Score: 0
    Social Score: 0
    Governance Score: 0

    ESG Performance: unknown

    Peer Group: unknown

    Peer Esg Score Performance: unknown

    Rating Year: unknown

    Rating Month: unknown

    Max Age: unknown

    Percentile: unknown